The combination of new drugs, new treatments and advanced data analytics solutions creates superior opportunities for patients, making treatment more effective, more affordable and less intrusive, with a positive impact on their quality of life.
Back to Oil ! is an elegy devoted to the oilman’s works and days on the ground, in a world where digitalization makes reality abstract. Excellence comes from the simplicity of concrete gestures and the agrarian rites of oil production.
Cost reductions achieved by adopting new oilfield technologies are critical to improve the resilience of Exploration and Production margins, especially for subsea assets. However, new cost-effective technologies can only be deployed successfully with sustained and targeted R&D efforts.
As a biopharmaceutical product approaches the end of its patent life, executives believe that the product’s demise is inevitable and will happen at great speed. They begin to worry about the rapid loss of revenue that will be brought about by the entry of generic alternatives into the market.
The increasing need for new and creative types of partnerships between national oil companies (NOCs) and other operators and service companies has created a difficult task for their management.
National oil companies (NOCs) are becoming ever more influential in today’s oil and gas environment, dominating production output and expanding their footprints beyond their local boundaries.
In 2011 the tragic events at Fukushima called the nuclear industry to a sudden halt. In the months after the accident, several nuclear programmes for example in Switzerland, Thailand, The Netherlands and to some extent also in the U.S., were put on hold or stopped entirely.